Source: Diabetes research and clinical practice. Unidade: FM
Subjects: DEGENERAÇÃO MACULAR, DIABETES MELLITUS, GLICEMIA, ANTICORPOS MONOCLONAIS
ABNT
MOTTA, Augusto A. L et al. Short-term effects of intravitreal bevacizumab in contrast sensitivity of patients with diabetic macular edema and optimizing glycemic control. Diabetes research and clinical practice, v. 149, p. 170-178, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.diabres.2019.02.002. Acesso em: 30 set. 2024.APA
Motta, A. A. L., Bonanomi, M. T. B. C., Ferraz, D. A., Preti, R. C., Sophie, R., Abalem, M. F., et al. (2019). Short-term effects of intravitreal bevacizumab in contrast sensitivity of patients with diabetic macular edema and optimizing glycemic control. Diabetes research and clinical practice, 149, 170-178. doi:10.1016/j.diabres.2019.02.002NLM
Motta AAL, Bonanomi MTBC, Ferraz DA, Preti RC, Sophie R, Abalem MF, Queiroz MS, Pimentel SLG, Takahashi WY, Damico FM. Short-term effects of intravitreal bevacizumab in contrast sensitivity of patients with diabetic macular edema and optimizing glycemic control [Internet]. Diabetes research and clinical practice. 2019 ; 149 170-178.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.diabres.2019.02.002Vancouver
Motta AAL, Bonanomi MTBC, Ferraz DA, Preti RC, Sophie R, Abalem MF, Queiroz MS, Pimentel SLG, Takahashi WY, Damico FM. Short-term effects of intravitreal bevacizumab in contrast sensitivity of patients with diabetic macular edema and optimizing glycemic control [Internet]. Diabetes research and clinical practice. 2019 ; 149 170-178.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.diabres.2019.02.002